SEC Form 6-K filed by Golden Sun Health Technology Group Limited
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2024
Commission File Number: 001-41425
Golden Sun Health Technology Group Limited
Profit Huiyin Square North Building 2F
Huashan 2018, Unit 1001
Xuhui District, Shanghai, China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Exhibit Index
| Exhibit No. | Description | |
| 99.1 | Press Release - Golden Sun Health Technology Group Limited Regains Compliance with Nasdaq Continued Listing Requirement |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: May 7, 2024
| Golden Sun Health Technology Group Limited | ||
| By: | /s/ Xueyuan Weng | |
| Name: | Xueyuan Weng | |
| Title: | Chief Executive Officer | |
2